Ixchiq
Product Images NDC 42515-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ixchiq (NDC 42515-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Valneva Scotland Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
An instructional diagram depicting the rotation or unscrewing motion of a needle attached to a syringe. The syringe is drawn with a plunger at the base and a needle at the top, indicated by a curved arrow around the needle, labeled with the number 1.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
An instructional diagram showing a syringe attached to a vial with a lever cap being opened. The image likely demonstrates part of a preparation or administration step involving withdrawal of liquid from the vial.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
Instructional diagram showing a syringe drawing liquid from a vial. The syringe plunger moves upwards, indicated by an arrow and faint images of the syringe in different positions. Below, an arrow circles the vial, suggesting rotation. A clock icon with "1 min" indicates to wait or perform this step for one minute.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
Illustration showing a syringe drawing liquid from a vial, with a hand gripping the vial and an arrow pointing upward to indicate the direction for withdrawing the fluid. The image is part of step 5 in a sequence.*
FDA Label Image

Carton (Mu Bcus01.1)

Carton (Mu Bcus01.1)
Packaging label for IXCHIQ, a Chikungunya Vaccine, Live, solution for intramuscular injection by Valneva Scotland Ltd. The label includes instructions for storage at 2°C to 8°C and reconstitution of the vaccine from lyophilized antigen and sterile water diluent components. The label states the vaccine is for adults 18 years and older, with a single dose of approximately 0.5 mL after reconstitution. The design includes a barcode and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.